Efficacy and Safety of Local Glucocorticoids for the Treatment of Acute Radiation-Induced Intestinal Injury

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorGeneral Hospital of Shenyang Military Region

About this trial

Due to the increasing number and prolonged survival of malignant tumor patients treated with radiotherapy, the complication, such as acute radiation-induced intestinal injury, has become increasingly significant. Glucocorticoids may play a therapeutic role by regulating the inflammatory response in patients with acute radiation-induced intestinal injury. However, the conclusions of related studies were controversial.

Eligibility criteria

Qualifiers

Grade II-III acute radiation-induced rectosigmoid injury

Signed informed consents

Age ≥18 years

Rstimated survival time >1 year

Disqualifiers

Absolute contraindications to glucocorticoids

A history of glucocorticoids treatment within 3 months

Inflammatory bowel disease or infectious intestinal disease

Recurrence of malignant tumor

Trial design

Treatments tested in this trial

  • Dexamethasone
  • Antibiotics, probiotics, vitamins, antidiarrheal drugs, enteral nutrition, and endoscopic argon plasma coagulation

Treatment groups

60 Participants
are divided into 2 treatment groups